The new, advanced X-Ray machine at The Royal Marsden will allow more patients to be treated due to its advanced features.
Interventional radiology (IR) was an important part of Dame Deborah’s treatment at The Royal Marsden. IR uses imaging techniques to treat cancer in a minimally invasive way. Often used as an alternative to surgery, imaging methods such as real-time x-rays, ultrasound, CT or MRI scanning, are used to guide treatment directly to the cancer site.
The Interventional Radiology (IR) room is now operational. Thanks to your support, they’ve installed the Philips Azurion 7 C20, the most advanced IR equipment on the market. The upgraded machine will significantly improve the IR functionality at the Royal Marsden:
• They will have the highest quality image resolution thanks to the latest detectors and software that will enable patients to have quicker and more accurate diagnosis and treatment.
• State-of-the-art 3D navigation tools will enable the operator to manoeuvre the radiation probe with greater accuracy through the patient’s anatomy, meaning reduced radiation doses for patients and staff.
• With more efficient equipment, there will be less downtime and service disruption, meaning more targeted therapies can be offered to more patients. This will also mean the IR team can conduct more research into new IR diagnosis and treatment techniques.
Image: Alistair James, Heather James & Sarah Wierczorak with Dr Nicos Fotiadis and the IR team in the IR room at The Royal Marsden.
A new Bowelbabe Fund research consultant and fellow at The Royal Marsden.
In April 2024 we committed to fund the appointment of a new gastrointestinal (GI) Consultant and Clinical Fellow to join Professor David Cunningham's Team at the Royal Marsden Cancer Hospital. Professor Cunningham was Deborah's oncologist. These two roles will lead early phase clinical trials and focus on researching personalised medicines including cancer vaccines.
The GI Consultant is now in post, we're pleased to be supporting Hazel Lote. Hazel has worked closely with Professor Cunningham for many years and has a very strong research background, having spent time at the Institute of Cancer Research and The Royal Marsden.
Now, the priority is recruiting the clinical research fellow postholder.
